ID: hyp-SDA-2026-04-08-gap-pubmed-20260406-0
Hypothesis
Metabolic Memory Support Therapy
Long-distance migration requires precise metabolic timing coordinated with memory systems.
spatial memory
EvidencePending (0%)📖 5 cit🗣 1 debates✓ 5 support✗ 1 oppose
✓ All Quality Gates Passed
🧪 Overview
Long-distance migration requires precise metabolic timing coordinated with memory systems. Optimizing brain metabolism through migration-inspired protocols could enhance memory formation and retrieval in metabolic disorders affecting cognition.
🧬 Mechanism
🔗 Mechanism from KG for AMPK, PGC-1α, mitochondrial complex proteins
Auto-built from this analysis's top knowledge-graph edges.
graph TD
AMPK["AMPK"] -->|regulates| mitochondrial_biogenesis["mitochondrial_biogenesis"]
PGC_1_["PGC-1α"] -->|activates| oxidative_metabolism["oxidative_metabolism"]
BDNF["BDNF"] -->|enhances| synaptic_plasticity["synaptic_plasticity"]
BDNF_1["BDNF"] -->|activates| memory_formation["memory formation"]
Glucocorticoid_receptor["Glucocorticoid receptor"] -->|regulates| Stress_response["Stress response"]
CLOCK["CLOCK"] -->|regulates| Circadian_rhythm["Circadian rhythm"]
BMAL1["BMAL1"] -->|regulates| Circadian_rhythm_2["Circadian rhythm"]
DNMT3A["DNMT3A"] -->|regulates| EPIGENETIC_MODIFICATION["EPIGENETIC MODIFICATION"]
n5_azacytidine["5-azacytidine"] -.->|inhibits| DNMT3A_3["DNMT3A"]
Decitabine["Decitabine"] -.->|inhibits| DNMT3A_4["DNMT3A"]
hippocampal_place_cells["hippocampal_place_cells"] -->|regulates| spatial_memory["spatial memory"]
FKBP5["FKBP5"] -->|modulates| glucocorticoid_signaling["glucocorticoid_signaling"]
style AMPK fill:#ce93d8,stroke:#333,color:#000
style mitochondrial_biogenesis fill:#81c784,stroke:#333,color:#000
style PGC_1_ fill:#ce93d8,stroke:#333,color:#000
style oxidative_metabolism fill:#81c784,stroke:#333,color:#000
style BDNF fill:#ce93d8,stroke:#333,color:#000
style synaptic_plasticity fill:#81c784,stroke:#333,color:#000
style BDNF_1 fill:#ce93d8,stroke:#333,color:#000
style memory_formation fill:#4fc3f7,stroke:#333,color:#000
style Glucocorticoid_receptor fill:#4fc3f7,stroke:#333,color:#000
style Stress_response fill:#4fc3f7,stroke:#333,color:#000
style CLOCK fill:#ce93d8,stroke:#333,color:#000
style Circadian_rhythm fill:#81c784,stroke:#333,color:#000
style BMAL1 fill:#ce93d8,stroke:#333,color:#000
style Circadian_rhythm_2 fill:#81c784,stroke:#333,color:#000
style DNMT3A fill:#ce93d8,stroke:#333,color:#000
style EPIGENETIC_MODIFICATION fill:#4fc3f7,stroke:#333,color:#000
style n5_azacytidine fill:#4fc3f7,stroke:#333,color:#000
style DNMT3A_3 fill:#ce93d8,stroke:#333,color:#000
style Decitabine fill:#4fc3f7,stroke:#333,color:#000
style DNMT3A_4 fill:#ce93d8,stroke:#333,color:#000
style hippocampal_place_cells fill:#4fc3f7,stroke:#333,color:#000
style spatial_memory fill:#4fc3f7,stroke:#333,color:#000
style FKBP5 fill:#ce93d8,stroke:#333,color:#000
style glucocorticoid_signaling fill:#81c784,stroke:#333,color:#000⚖️ Evidence
⚖️ Evidence Matrix5 supports0 contradicts
Supports
α-Ketoglutarate prevents hyperlipidemia-induced fatty liver mitochondrial dysfunction and oxidative stress by activating the AMPK-pgc-1α/Nrf2 pathway.
Supports
PGC-1α-mediated regulation of mitochondrial function and physiological implications.
Supports
AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance.
Supports
Berberine improves cardiac insufficiency through AMPK/PGC-1α signaling-mediated mitochondrial homeostasis and apoptosis in HFpEF mice.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — AMPK
No curated PDB or AlphaFold mapping for AMPK yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for AMPK, PGC-1α, mitochondrial complex proteins.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0535
Events (7d)
0
Price History
▲6.0%💾 Resource Usage
LLM Tokens
14,614
$0.0877
Total Cost
$0.0877
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF adult APP/PS1 transgenic mice (Alzheimer's disease model) receive bilateral hippocampal AAV9-mediated PGC-1α overexpression (1×10^9 vg) THEN spatial memory will improve by ≥30% on Y-maze spontaneou | Y-maze alternation rate will increase from ~50% (AAV9-eGFP) to ≥65%; object location discrimination index will increase from ~0.52 to ≥0.65; hippocampal mitocho | — no observation — | pending | 0.58 |
| IF C57BL/6J mice with 16 weeks of high-fat diet-induced obesity are treated with chronic AICAR (AMPK activator, 500 mg/kg IP, daily) for 4 weeks THEN spatial memory performance will improve by ≥25% on | Mean platform location quadrant time will increase from ~18 seconds (obese baseline) to ≥22.5 seconds; platform crossing frequency will increase from ~2.5 to ≥3 | — no observation — | pending | 0.65 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF C57BL/6J mice with 16 weeks of high-fat diet-induced obesity are treated with chronic AICAR (AMPK activator, 500 mg/kg IP, daily) for 4 weeks THEN spatial memory performance will improve by ≥25% on the Morris water maze probe trial compared to vehicle-treated obese controls within 5 weeks of trea
Predicted outcome: Mean platform location quadrant time will increase from ~18 seconds (obese baseline) to ≥22.5 seconds; platform crossing frequency will increase from
Falsification: No statistically significant improvement (p≥0.05) in Morris water maze probe trial performance, OR performance worsens in AICAR-treated animals compared to vehicle controls
pendingconf 58%
IF adult APP/PS1 transgenic mice (Alzheimer's disease model) receive bilateral hippocampal AAV9-mediated PGC-1α overexpression (1×10^9 vg) THEN spatial memory will improve by ≥30% on Y-maze spontaneous alternation and object location discrimination will improve by ≥25% at 8 weeks post-injection comp
Predicted outcome: Y-maze alternation rate will increase from ~50% (AAV9-eGFP) to ≥65%; object location discrimination index will increase from ~0.52 to ≥0.65; hippocamp
Falsification: No improvement in behavioral metrics (p≥0.05), no change in mitochondrial biogenesis markers (PGC-1α, NRF1, TFAM), OR AAV9-PGC-1α expression fails to produce measurable increases in mitochondrial comp
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesis
| source | v1_phase_c_backfill |
| origin_type | debate_synthesis |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.